This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wollenberg, G. K. Articles by Remick, D. G. Search for Related Content PubMed PubMed Citation Articles by Wollenberg, G. K. Articles by Remick, D. G.

American Journal of Pathology, Vol 143, 1121-1130, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture

GK Wollenberg, LE DeForge, G Bolgos and DG Remick
Department of Pathology, University of Michigan Medical School, Ann Arbor.

To investigate the differences in cytokine regulation in vitro as compared to in vivo, we examined the synthesis of tumor necrosis factor- alpha (TNF-alpha) and interleukin-6 (IL-6) by peritoneal macrophages in response to lipopolysaccharide (LPS). Mice (CBA/J) were primed with an intraperitoneal injection of complete Freund's adjuvant and after 2 weeks, peritoneal cells were harvested for culture or mice were injected intraperitoneally with LPS for in vivo studies. In ascites fluid, TNF-alpha peaked 1 hour after LPS and returned to baseline levels by 4 hours. In contrast, TNF-alpha in the media reached maximum at 7 hours. Expression of TNF-alpha messenger (m)RNA in vivo was rapid but transient, as levels peaked at 15 minutes and returned to baseline 1 hour after LPS. In contrast, TNF-alpha mRNA in vitro became maximal at 1 hour, but remained elevated to 5 hours after LPS. In vivo, IL-6 in ascites fluid peaked at 2 hours, whereas in vitro, IL-6 continued increasing to 24 hours. In vivo, IL-6 mRNA reached maximum at 30 minutes, but fell below baseline by 1.5 hours after LPS. In contrast, IL-6 mRNA in vitro was sustained at maximal expression between 5 to 9 hours after LPS. These results demonstrate that both TNF-alpha and IL-6 synthesis is more rapid in vivo than in vitro. The rapid kinetics of cytokine expression in vivo must considered when designing strategies to inhibit cytokine action in vivo.

This article has been cited by other articles:

				D. R. Call, J. A. Nemzek, S. J. Ebong, G. L. Bolgos, D. E. Newcomb, and D. G. Remick Ratio of Local to Systemic Chemokine Concentrations Regulates Neutrophil Recruitment Am. J. Pathol., February 1, 2001; 158(2): 715 - 721. [Abstract] [Full Text] [PDF]

				P. Gozzi, I. Påhlman, L. Palmér, A. Grönberg, and a. S. Persson Pharmacokinetic-Pharmacodynamic Modeling of the Immunomodulating Agent Susalimod and Experimentally Induced Tumor Necrosis Factor-alpha Levels in the Mouse J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 199 - 203. [Abstract] [Full Text]

				T. A. Ignatowski and J. M. Bidlack Differential kappa -Opioid Receptor Expression on Mouse Lymphocytes at Varying Stages of Maturation and on Mouse Macrophages after Selective Elicitation J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 863 - 870. [Abstract] [Full Text]

				J. Soltys and M. T. Quinn Modulation of Endotoxin- and Enterotoxin-Induced Cytokine Release by In Vivo Treatment with beta -(1,6)-Branched beta -(1,3)-Glucan Infect. Immun., January 1, 1999; 67(1): 244 - 252. [Abstract] [Full Text] [PDF]

				S. Guang Ren, J. Seliktar, X. Li, G. D. Braunstein, and S. Melmed Measurement of Leukemia Inhibitory Factor in Biological Fluids by Radioimmunoassay J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1275 - 1283. [Abstract] [Full Text]

				R. Silverstein, W.M. Johnson, S.E. Bucklin, and D.C. Johnson The protein kinase C activator PMA modulates LPS lethality in normal mice and protects against LPS lethality in D-galactosamine-sensitized mice Innate Immunity, February 1, 1996; 3(1): 29 - 37. [Abstract] [PDF]